Über die therapentische Verwendung von α-Methyl-DOPA beim Careinoidsyndrom
- 1 September 1961
- journal article
- Published by Springer Nature in Klinische Wochenschrift
- Vol. 39 (18) , 973
- https://doi.org/10.1007/bf01482661
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Use of Alpha-Methyl-Dopa (Alpha-Methyl-3,4-Dihydroxy-DL-Phenylalanine) in the Management of the Carcinoid SyndromeNew England Journal of Medicine, 1961
- Serotonin Synthesis in Carcinoid PatientsNew England Journal of Medicine, 1960
- Decarboxylase Inhibition and Blood Pressure Reduction by α-Methyl-3,4-Dihydroxy-DL-phenylalanineScience, 1960
- THE IDENTIFICATION OF 5-HYDROXY-3-INDOLEACETIC ACID IN NORMAL URINE AND A METHOD FOR ITS ASSAYJournal of Biological Chemistry, 1955